Apr 1, 2024 4:15pm EDT Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Mar 28, 2024 9:32am EDT Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering